Continuing Legal Education (CLE)
In This Section
AIPLA Rapid Response Webinar: Arthrex and its Impact on Your Practice
July 7, 2021 12:00 PM to 1:15 PM
Member-benefit exclusive! CLE credit is available on a limited basis.
On June 21, 2021, in a 5-4 decision, the U.S. Supreme Court issued its decision in United States v. Arthrex, Inc., Nos. 19-1434, 19-1452, and 19-1458, reversing and vacating the Federal Circuit decision. Chief Justice Roberts issued the majority decision, holding that the unreviewable authority wielded by Administrative Patent Judges (APJs) during inter partes review is constitutionally incompatible with their appointment by the Secretary of Commerce to an inferior office. The majority found that “35 U. S. C. § 6(c) is unenforceable as applied to the Director insofar as it prevents the Director from reviewing the decisions of the PTAB on his own.” In this case, the Court determined that an appropriate remedy is a remand to the Acting Director to decide whether to rehear the petition filed by Smith & Nephew. Additionally, the Court stated that Arthrex is not entitled to a hearing before a new panel of APJs. The Court’s full decision may be found here.
Please join our expert panel, including representatives for each of the parties to the case, to help us understand the Supreme Court’s decision, its implications and what you need to know for your practice. The panel will be moderated by AIPLA Sophie Wang, who authored AIPLA’s amicus brief, and the panelists include Malcolm Stewart, Mark Perry, and Robert Kry. Join in on July 7, 2021, from 12-1:15 PM ET, for an informative discussion.
This event is FREE to AIPLA members who are not requesting CLE.
Limited CLE is available and standard webinar pricing applies to those requesting CLE for the listed states.
CLE is included for our All Access Pass holders and Corporate Subscribers for the states listed below.
Pricing is for those requesting CLE in the states listed below.
Solo Practice/Small Firm Members: $65
CLE credit for this webinar is only available for the following states:
- Alaska
- California
- New Hampshire
- New Mexico
- New York
- New Jersey
- Pennsylvania
- Vermont
ATTENTION attorneys in Pennsylvania:
This state mandate attorneys can only view a webinar independently at their own computer to receive CLE credit. Multiple attendees prohibited.
Cancellation Policy:
To get full refund, registrant must request refund five (5) days prior to live event. If less than five (5) days, registrant is transferred to product.
System requirements:
Webinar access is compatible with any Windows 7 or later computer, Android OS devices, or Apple/iOS devices. Check system compatibility here.
Accessibility for hearing impaired:
AIPLA’s webinars are available and accessible to individuals who are hearing impaired. If anyone at your location would like to know more about accommodations, please contact cle@aipla.org. We ask that you let us know at least 7 business days out from the webinar, to ensure that we can identify and deploy the solution that best fits our registrants needs.
Disclaimer: AIPLA is a nonprofit national bar association. The sole purpose of this CLE program is to provide educational and informational content. AIPLA does not provide legal services or advice. The opinions, views and other statements expressed by contributors to this CLE program are solely those of the contributors. These opinions, views and statements of the contributors do not necessarily represent those of AIPLA and should not be construed as such.
News
-
AIPLA Comments on Inventorship Guidance for AI-Assisted Inventions
May 15, 2024
Arlington, VA. May 10, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO in response to the recently-published Inventorship Guidance for AI-Assisted Inventions. -
AIPLA Comments to USPTO on Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace
May 14, 2024
Arlington, VA. May 14, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the USPTO’s Request for Comment regarding Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace. -
AIPLA Files Amicus Brief in REGENXBIO Inc. v. Sarepta Therapeutics, Inc.
May 14, 2024
Arlington, VA. May 10, 2024 - The American Intellectual Property Law Association (AIPLA) filed an amicus brief in support of neither party with the Court of Appeals for the Federal Circuit in REGENXBIO Inc. v. Sarepta Therapeutics, Inc., a case on appeal from the U.S. District Court for the District of Delaware. The district court held that cultured host cells containing a recombinant nucleic acid molecule were not eligible for patent protection under Section 101 of the Patent Act because the individual nucleic acid sequences used in the recombinant molecule were not modified or changed from their naturally occurring state. -
.png?sfvrsn=143e8f56_1 "supreme court")
Supreme Court Affirms Eleventh Circuit’s Ruling in Warner Chappell Music, Inc. v. Sherman Nealy
May 9, 2024
On May 9, 2024, the Supreme Court issued a 6-3 decision in Warner Chappell Music, Inc., et al. v. Sherman Nealy, et al., affirming the Eleventh Circuit’s ruling that, provided suit is timely filed under the discovery rule, copyright damages are recoverable for infringements occurring prior to the Copyright Act’s three-year statute of limitations. The majority opinion is consistent with the amicus brief filed by AIPLA on December 1, 2023. To read the opinion of the Court, please click here. -
AIPLA Comments to Copyright Office on Group Registration of Two-Dimensional Artwork
April 2, 2024
Arlington, VA. April 1, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office's Notice of Proposed Rulemaking related to group registration of two-dimensional artwork.